Literature DB >> 31048326

AKI in Patients Receiving Immune Checkpoint Inhibitors.

Mark A Perazella1,2, Ben Sprangers3,4.   

Abstract

Entities:  

Keywords:  Programmed Cell Death 1 Receptor; acute interstitial nephritis; acute kidney injury; acute tubular injury; immune checkpoint inhibitor; nephrotoxicity

Year:  2019        PMID： 31048326      PMCID： PMC6625632          DOI： 10.2215/CJN.02340219

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

Review 1.  Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.

Authors:  Mark A Perazella; Anushree C Shirali
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

Review 2.  Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.

Authors:  Michael A Postow; Robert Sidlow; Matthew D Hellmann
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

3.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Julie R Brahmer; Christina Lacchetti; Bryan J Schneider; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marc S Ernstoff; Jennifer M Gardner; Pamela Ginex; Sigrun Hallmeyer; Jennifer Holter Chakrabarty; Natasha B Leighl; Jennifer S Mammen; David F McDermott; Aung Naing; Loretta J Nastoupil; Tanyanika Phillips; Laura D Porter; Igor Puzanov; Cristina A Reichner; Bianca D Santomasso; Carole Seigel; Alexander Spira; Maria E Suarez-Almazor; Yinghong Wang; Jeffrey S Weber; Jedd D Wolchok; John A Thompson
Journal:  J Clin Oncol       Date:  2018-02-14       Impact factor: 44.544

Review 4.  MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.

Authors:  Patrizia Leone; Eui-Cheol Shin; Federico Perosa; Angelo Vacca; Franco Dammacco; Vito Racanelli
Journal:  J Natl Cancer Inst       Date:  2013-07-12       Impact factor: 13.506

5.  Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients.

Authors:  Anushree C Shirali; Mark A Perazella; Scott Gettinger
Journal:  Am J Kidney Dis       Date:  2016-04-22       Impact factor: 8.860

6.  Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.

Authors:  Frank B Cortazar; Kristen A Marrone; Megan L Troxell; Kenneth M Ralto; Melanie P Hoenig; Julie R Brahmer; Dung T Le; Evan J Lipson; Ilya G Glezerman; Jedd Wolchok; Lynn D Cornell; Paul Feldman; Michael B Stokes; Sarah A Zapata; F Stephen Hodi; Patrick A Ott; Michifumi Yamashita; David E Leaf
Journal:  Kidney Int       Date:  2016-06-07       Impact factor: 10.612

Review 7.  Cardiorenal complications of immune checkpoint inhibitors.

Authors:  Krishna Sury; Mark A Perazella; Anushree C Shirali
Journal:  Nat Rev Nephrol       Date:  2018-09       Impact factor: 28.314

Review 8.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

9.  Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience.

Authors:  Omar Mamlouk; Umut Selamet; Shana Machado; Maen Abdelrahim; William F Glass; Amanda Tchakarov; Lillian Gaber; Amit Lahoti; Biruh Workeneh; Sheldon Chen; Jamie Lin; Noha Abdel-Wahab; Jean Tayar; Huifang Lu; Maria Suarez-Almazor; Nizar Tannir; Cassian Yee; Adi Diab; Ala Abudayyeh
Journal:  J Immunother Cancer       Date:  2019-01-06       Impact factor: 13.751

10.  Renal toxicities associated with pembrolizumab.

Authors:  Hassan Izzedine; Alexis Mathian; Stephane Champiat; Cécile Picard; Christine Mateus; Emilie Routier; Andrea Varga; David Malka; Alexandra Leary; Judith Michels; Jean-Marie Michot; Aurélien Marabelle; Olivier Lambotte; Zahir Amoura; Jean-Charles Soria; Sihem Kaaki; Nathalie Quellard; Jean-Michel Goujon; Isabelle Brocheriou
Journal:  Clin Kidney J       Date:  2018-11-09
  10 in total
  12 in total

1.  Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: PRO.

Authors:  Mark Eijgelsheim; Ben Sprangers
Journal:  Kidney360       Date:  2020-02-11

Review 2.  Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.

Authors:  Shruti Gupta; Frank B Cortazar; Leonardo V Riella; David E Leaf
Journal:  Kidney360       Date:  2020-01-14

3.  Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: Commentary.

Authors:  Mark A Perazella
Journal:  Kidney360       Date:  2020-02-11

Review 4.  Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury.

Authors:  Ben Sprangers; David E Leaf; Camillo Porta; Maria José Soler; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2022-09-27       Impact factor: 42.439

Review 5.  Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function.

Authors:  Łukasz Mielczarek; Anna Brodziak; Paweł Sobczuk; Maciej Kawecki; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Cancer Chemother Pharmacol       Date:  2021-03-25       Impact factor: 3.333

6.  Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.

Authors:  Marije S Koks; Gurbey Ocak; Britt B M Suelmann; Cornelia A R Hulsbergen-Veelken; Saskia Haitjema; Marieke E Vianen; Marianne C Verhaar; Karin A H Kaasjager; Meriem Khairoun
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

Review 7.  Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management.

Authors:  Harish Seethapathy; Sandra M Herrmann; Meghan E Sise
Journal:  Kidney Med       Date:  2021-10-08

8.  Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.

Authors:  Frank B Cortazar; Zoe A Kibbelaar; Ilya G Glezerman; Ala Abudayyeh; Omar Mamlouk; Shveta S Motwani; Naoka Murakami; Sandra M Herrmann; Sandhya Manohar; Anushree C Shirali; Abhijat Kitchlu; Shayan Shirazian; Amer Assal; Anitha Vijayan; Amanda DeMauro Renaghan; David I Ortiz-Melo; Sunil Rangarajan; A Bilal Malik; Jonathan J Hogan; Alex R Dinh; Daniel Sanghoon Shin; Kristen A Marrone; Zain Mithani; Douglas B Johnson; Afrooz Hosseini; Deekchha Uprety; Shreyak Sharma; Shruti Gupta; Kerry L Reynolds; Meghan E Sise; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2020-01-02       Impact factor: 10.121

9.  Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience.

Authors:  Diana Oleas; Mónica Bolufer; Irene Agraz; Enriqueta Felip; Eva Muñoz; Alejandra Gabaldón; Roxana Bury; Eugenia Espinel; Daniel Serón; Clara García-Carro; María José Soler
Journal:  Clin Kidney J       Date:  2020-02-10

10.  Acute Interstitial Nephritis: A Rare and Unusual Side Effect of Omalizumab.

Authors:  Rocky Yang; Leila Moosavi; Sabitha Eppanapally; Ayham Aboeed; Augustine Munoz
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.